Company News

The MIRA Surgical System Proceeds to FDA Substantive Review for Market Authorization Under the De Novo Classification Pathway

Virtual Incision Has Achieved a Significant Milestone in Its De Novo Request and is Closer to Potential Commercial Readiness  Lincoln, Neb. – May 18, 2023 – Virtual Incision Corporation today announced its De Novo request was submitted and is under substantive review by the U.S. Food and Drug Administration (FDA). [...]

2023-05-19T18:55:06+01:00May 18th, 2023|All News, Company News|

Relievant Medsystems Announces More Than 10,000 Patients Treated with the Intracept® Procedure for Vertebrogenic Low Back Pain

MINNEAPOLIS, May 09, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low back pain, today announced that more than 10,000 patients have been treated with the Intracept® Procedure. This is the latest in a series of milestone accomplishments as the [...]

2023-05-10T08:04:11+01:00May 9th, 2023|All News, Company News|

Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain

MINNEAPOLIS, April 19, 2023 (GLOBE NEWSWIRE) --  Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that it has completed the close of its $50 million Series G financing. The financing was led by [...]

2023-04-20T15:51:11+01:00April 19th, 2023|All News, Company News|

Gynesonics Names Industry Veteran Skip Baldino President and CEO, Announces $25M Financing to Expand Worldwide Commercialization

REDWOOD CITY, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced that Skip Baldino was appointed in early March to the role of President and Chief Executive Officer of the company. Mr. [...]

2023-04-13T10:58:51+01:00April 13th, 2023|All News, Company News|

Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Basel, 17 March 2023: Medartis Holding AG (SIX: MED), an orthopaedic company specialising in head and extremity surgery, today announced the successful completion of a small capital increase of CHF 30 million in a private placement to finance an additional stake [...]

2023-05-02T10:31:51+01:00March 17th, 2023|All News, Company News|

The Innovation Continues for Robotic-Assisted Surgery – Virtual Incision Completes FDA Investigational Device Exemption (IDE) Clinical Study for MIRA

Study results will be used to support the first FDA De Novo request for market authorization of the MIRA Surgical System as Virtual Incision makes progress towards its mission to expand RAS access Lincoln, Neb. – February 22, 2023 – Virtual Incision Corporation, a medical device company spearheading the [...]

2023-03-28T14:20:01+01:00February 22nd, 2023|All News, Company News|

Miach Orthopaedics Secures $40 Million Financing – Funds to Expand U.S. Commercialization of BEAR® Implant for Treatment of ACL Tears

WESTBOROUGH, Massachusetts – January 24, 2023 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $40 million financing round. The funds will enable ongoing operations and expand [...]

2023-03-28T14:20:57+01:00January 25th, 2023|All News, Blog, Company News, Investment, Medtech|

HealthJoy Raises $60M Series D to Power HR Leaders Through a New Era of Workplace and Healthcare Benefits

CHICAGO, Oct. 27, 2022 - HealthJoy, a healthcare navigation platform that drives benefits satisfaction, improves care outcomes, improves employee satisfaction and reduces HR burden, today announced it has raised $60M in Series D funding. Valspring Capital led the round with participation from new investors Endeavour Vision and CIBC Innovation [...]

2023-03-28T14:41:47+01:00October 27th, 2022|All News, Blog, Company News, Investment, Medtech|

Endeavour Vision adds Kestra Medical Technologies to EMG II Portfolio

Endeavour Vision is pleased to announce the addition of Kestra Medical Technologies to its portfolio – a company poised to disrupt the billion-dollar wearable cardioverter defibrillator (WCD) market. Kestra is bringing much-needed innovation to patients at risk of sudden cardiac arrest. Kestra’s ASSURE WCD automatically detects the irregularities in [...]

2023-03-28T14:42:45+01:00August 26th, 2022|All News, Blog, Company News, Investment, Medtech|

Nalu Medical, Inc. Names Thomas West President and Chief Executive Officer

CARLSBAD, CALIFORNIA, July 14, 2022 – Nalu Medical, Inc. (“Nalu”), a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced today that the Board of Directors has appointed Thomas “Tom” West as President and Chief Executive Officer. This leadership appointment is effective on August [...]

2023-02-22T12:06:39+00:00July 15th, 2022|All News, Company News|
Go to Top